Regulation
FDA grants 510(k) clearance to Emboliner system for TAVR procedures
Emboline received FDA 510(k) clearance for its Emboliner embolic protection system, designed for transcatheter aortic valve replacement (TAVR) and related cardiac procedures. The clearance enables the company to market the device in the US for use during these interventional cardiology procedures.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network